{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:44:26Z","timestamp":1786977866727,"version":"build-2736575974"},"reference-count":49,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T00:00:00Z","timestamp":1288742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Searching for efficacious and safe agents for the chemoprevention and therapy of prostate cancer has become the top priority of research. The objective of this study was to determine the effects of a group of tanshinones from a Chinese herb\n                    <jats:italic>Salvia Miltiorrhiza<\/jats:italic>\n                    , cryptotanshinone (CT), tanshinone IIA (T2A) and tanshinone I (T1) on prostate cancer. The\n                    <jats:italic>in vitro<\/jats:italic>\n                    studies showed that these tanshinones inhibited the growth of human prostate cancer cell lines in a dose\u2010dependent manner via cell cycle arrest and apoptosis induction. Among three compounds, T1 had the most potent activity with IC\n                    <jats:sub>50<\/jats:sub>\n                    s around 3\u20136 \u03bcM. On the other hand, tanshinones had much less adverse effects on the growth of normal prostate epithelial cells. The epigenetic pathway focused array assay identified Aurora A kinase as a possible target of tanshinone actions. The expression of Aurora A was overexpressed in prostate cancer cell lines. Moreover, knockdown of Aurora A in prostate cancer cells significantly decreased cell growth. Tanshinones significantly downregulated the Aurora A expression, suggesting Aurora A may be a functional target of tanshinones. Tanshinones, especially T1, also showed potent anti\u2010angiogenesis activity\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    . Furthermore, T1 inhibited the growth of DU145 prostate tumor in mice associated with induction of apoptosis, decrease of proliferation, inhibition of angiogenesis and downregulation of Aurora A, whereas it did not alter food intake or body weight. Our results support that T1 may be an efficacious and safe chemopreventive or therapeutic agent against prostate cancer progression.\n                  <\/jats:p>","DOI":"10.1002\/ijc.25678","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T11:27:41Z","timestamp":1284636461000},"page":"1042-1052","source":"Crossref","is-referenced-by-count":110,"title":["Bioactive tanshinones in\n                    <i>Salvia miltiorrhiza<\/i>\n                    inhibit the growth of prostate cancer cells\n                    <i>in vitro<\/i>\n                    and in mice"],"prefix":"10.1002","volume":"129","author":[{"given":"Yi","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Abdolmaleky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin\u2010Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.18.1569"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005282630"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1078\/0944-7113-00321"},{"key":"e_1_2_6_5_2","first-page":"207","article-title":"Alteration of activities of telomerase in tanshinone IIA inducing apoptosis of the leukemia cells","volume":"30","author":"Song Y","year":"2005","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/emm.1999.28"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-8741(99)00059-8"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-2288"},{"key":"e_1_2_6_9_2","first-page":"485","article-title":"Tanshinone I effectively induces apoptosis in estrogen receptor\u2010positive (MCF\u20107) and estrogen receptor\u2010negative (MDA\u2010MB\u2010231) breast cancer cells","volume":"33","author":"Nizamutdinova IT","year":"2008","journal-title":"Int J Oncol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20880"},{"key":"e_1_2_6_11_2","first-page":"357","article-title":"Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl\u2010xL ratios","volume":"22","author":"Su CC","year":"2008","journal-title":"Int J Mol Med"},{"key":"e_1_2_6_12_2","first-page":"84","article-title":"A study on apoptosis of nasopharyngeal carcinoma cell line induced by Tanshinone II A and its molecular mechanism","volume":"33","author":"Yuan S","year":"2002","journal-title":"Hua Xi Yi Ke Da Xue Xue Bao"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-006-9242-x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.3892\/or_00000394"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i14.2024"},{"key":"e_1_2_6_16_2","first-page":"388","article-title":"An observation of the effect of tanshinone on cancer cell proliferation by Brdu and PCNA labeling","volume":"27","author":"Wang X","year":"1996","journal-title":"Hua Xi Yi Ke Da Xue Xue Bao"},{"key":"e_1_2_6_17_2","first-page":"412","article-title":"A preliminary study of the anti\u2010cancer effect of tanshinone on hepatic carcinoma and its mechanism of action in mice","volume":"18","author":"Wang X","year":"1996","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"e_1_2_6_18_2","first-page":"103","article-title":"Influence of blood\u2010activating drugs on adhesion and invasion of cells in lung cancer patients","volume":"19","author":"Zhang P","year":"1999","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2007.08.013"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1332"},{"key":"e_1_2_6_21_2","first-page":"5231","article-title":"The inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis","volume":"58","author":"Zhou J\u2010R","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mc.20300"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.3727\/096504008785055521"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgi097"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20206"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.864"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030660"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042307-200501000-00007"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0323"},{"key":"e_1_2_6_30_2","first-page":"283","article-title":"Targeting aurora2 kinase in oncogenesis: a structural bioinformatics approach to target validation and rational drug design","volume":"2","author":"Vankayalapati H","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1526"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2008.22"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.12.026"},{"key":"e_1_2_6_34_2","first-page":"991","article-title":"Overexpression of oncogenic STK15\/BTAK\/Aurora A kinase in human pancreatic cancer","volume":"9","author":"Li D","year":"2003","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2796"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1593\/neo.07322"},{"key":"e_1_2_6_37_2","first-page":"1","article-title":"Effect of aurora A on carcinogenesis of human prostate cancer","volume":"39","author":"Qu Y","year":"2008","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20247"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.09047.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0765"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-259523"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90142-6"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90471-P"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5388.487"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2008.06.013"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00642-1"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-3981"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2443.2005.00870.x"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.4-4-332"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2010.02.031"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.25678","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.25678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T23:58:57Z","timestamp":1697500737000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.25678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,3]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1002\/ijc.25678"],"URL":"https:\/\/doi.org\/10.1002\/ijc.25678","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,3]]}}}